LONDON (Reuters) - Shaping the future of personalized medicine is not all about developing expensive new drugs -- it will also mean revisiting older, cheaper medicines armed with new genetic knowledge.
Recent discoveries of genetic clues as to why medicines work better in some patients than others suggests combining new tests with old drugs will be a cost-effective approach -- attractive to governments...
* Says FDA did not request changes to current indications
Oct 9 (Reuters) - Spectrum Pharmaceuticals (SPPI.O) said it received a complete response letter from U.S. health regulators regarding its supplementary marketing application for its drug, Fusilev, to treat advanced metastatic colorectal cancer.
Spectrum, which received marketing approval for its another cancer drug last month,...
Reuters.com
NEW YORK - Eating plenty of folate may sharply reduce the risk of colorectal cancer, at least for women, South Korean researchers report.
In a study of 596 colorectal cancer patients and 509 healthy individuals, they found that the women who ate the most folate were at about two-thirds lower risk of the disease than women who consumed the smallest amount of the B vitamin.
But folate intake didn't significantly affect men's...
National Cancer Institute
NCI Cancer Bulletin
September 22, 2009 • Volume 6 / Number 18
Many herbs, dietary supplements, and even vitamins are suspected of interfering with chemotherapy and radiation therapy, and doctors now routinely advise patients who are undergoing cancer treatment to avoid taking these products.
At the same time, cancer researchers have been intrigued by the potent and beneficial biological activity shown by some natural products...
Oncology Nursing News
Tasheema Prince
September 22, 2009
Increasing the number of lymph nodes evaluated in a patient with stage III colorectal cancer is not a quality indicator of incidence or performance measure for the disease, says a report published in the Archives of Surgery (2009;144[7]:612-617).
According to the press release announcing the findings, colorectal cancer is the third most common type of cancer and the third leading cause of cancer-related...
